CSR and Sustainability in the News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 8, Issue 8

Merck & Co. and the Bill & Melinda Gates Foundation have formed a partnership to expand access to family planning, particularly in the developing world. Merck is pledging $25 million over eight years as part of its Merck for Mothers program, a 10-year initiative to reduce maternal mortality.

In other news, Merck & Co. has launched a three-year, $3-million initiative to support health departments in Atlanta, Houston, and Philadelphia, to enhance existing efforts and foster other innovative approaches to better serve people living with HIV/AIDS and prevent is further spread. The program supports the HIV Care Collaborative for Underserved Populations in the United States.

Merck & Co. also announced the first five partnership and inaugural class of fellows for newly formed Richard T. Clark Fellowship program, with PSI, a global nonprofit organized working to improve the health of people in the developing world. The program aims to strengthen the capability and reach of charitable organizations focused on improving access to health services and health outcomes.

Roche supported the “Roche Continents” program at the Salzburg Festival. The program invited 100 students from Europe to discover the role of innovation in the arts and science during a progam of workshops, discussions, and concert series.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here